From March 11, 2024 to March 31, 2024, the company has repurchased 611,267 shares, representing 0.15% for CNY 17.01 million. With this, the company has completed the repurchase of 611,267 shares, representing 0.15% for CNY 17.01 million under the buyback announced on March 12, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.82 CNY | +0.15% | -3.00% | -17.50% |
05-20 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
04-29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.50% | 1.53B | |
-1.62% | 90.85B | |
-0.92% | 39.02B | |
-10.26% | 33.46B | |
-19.10% | 14.51B | |
-5.71% | 13.22B | |
-9.76% | 11.65B | |
-47.31% | 10.57B | |
+6.52% | 9.23B | |
+137.06% | 7.71B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on March 12, 2024.